Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway
出版年份 2022 全文链接
标题
Eucommia, Cuscuta, and Drynaria Extracts Ameliorate Glucocorticoid-Induced Osteoporosis by Inhibiting Osteoclastogenesis Through PI3K/Akt Pathway
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-02-04
DOI
10.3389/fphar.2021.772944
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of anti-osteoporotic medications in patients with rebound-associated fractures after denosumab discontinuation
- (2021) Athanasios D. Anastasilakis et al. JOURNAL OF CLINICAL DENSITOMETRY
- Interleukin‑1 induces receptor activator of nuclear factor‑κB ligand‑independent osteoclast differentiation in RAW264.7 cells
- (2021) Rongdong Liao et al. Experimental and Therapeutic Medicine
- RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling
- (2020) Mohammad Tobeiha et al. Biomed Research International
- Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K‐AKT‐NFATc1 pathway
- (2020) Jin Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
- (2020) Pojchong Chotiyarnwong et al. Nature Reviews Endocrinology
- Ganoderma lucidum Immune Modulator Protein rLZ-8 Could Prevent and Reverse Bone Loss in Glucocorticoids-Induced Osteoporosis Rat Model
- (2020) Yong Yang et al. Frontiers in Pharmacology
- 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation
- (2020) Fatih Karadeniz et al. PHYTOMEDICINE
- Osteoblast-Osteoclast Communication and Bone Homeostasis
- (2020) Jung-Min Kim et al. Cells
- Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling
- (2020) Yongkui Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2
- (2019) Toshihisa Komori INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Concise Review: Mesenchymal Stem Cells: From Roots to Boost
- (2019) Anna Andrzejewska et al. STEM CELLS
- Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade
- (2019) Jeong-Tae Yeon et al. ARCHIVES OF PHARMACAL RESEARCH
- Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis
- (2019) Yanan An et al. FASEB JOURNAL
- Therapeutic Anabolic and Anticatabolic Benefits of Natural Chinese Medicines for the Treatment of Osteoporosis
- (2019) Jianbo He et al. Frontiers in Pharmacology
- Runx2, an inducer of osteoblast and chondrocyte differentiation
- (2018) Toshihisa Komori HISTOCHEMISTRY AND CELL BIOLOGY
- Tumor Necrosis Factor Alpha Promotes Osteoclast Formation Via PI3K/Akt Pathway-Mediated Blimp1 Expression Upregulation
- (2017) LeCheng Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats
- (2017) Rong Ping Zhou et al. PLoS One
- Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?
- (2016) Q Chen et al. CELL DEATH AND DIFFERENTIATION
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Natural products for treatment of osteoporosis: The effects and mechanisms on promoting osteoblast-mediated bone formation
- (2016) Jing An et al. LIFE SCIENCES
- Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression
- (2015) Xiang-zhou Zeng et al. ACTA PHARMACOLOGICA SINICA
- Bromo-honaucin A inhibits osteoclastogenic differentiation in RAW 264.7 cells via Akt and ERK signaling pathways
- (2015) Mahesh Sapkota et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway
- (2015) Chenyang Zhao et al. RNA Biology
- Potential Antiosteoporotic Agents from Plants: A Comprehensive Review
- (2013) Min Jia et al. Evidence-based Complementary and Alternative Medicine
- Ethanol Extracts of FreshDavallia formosana(WL1101) Inhibit Osteoclast Differentiation by Suppressing RANKL-Induced Nuclear Factor-κB Activation
- (2013) Tzu-Hung Lin et al. Evidence-based Complementary and Alternative Medicine
- Osteoprotegerin influences the bone resorption activity of osteoclasts
- (2013) YING-XIAO FU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Glucocorticoid-induced osteoporosis: An update on effects and management
- (2013) Bjoern Buehring et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pathophysiology of Osteoporosis
- (2012) Laura A.G. Armas et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Akt Induces Osteoclast Differentiation through Regulating the GSK3 /NFATc1 Signaling Cascade
- (2011) J. B. Moon et al. JOURNAL OF IMMUNOLOGY
- Denosumab: Anti-RANKL antibody
- (2009) Paul D. Miller Current Osteoporosis Reports
- Functions of RANKL/RANK/OPG in bone modeling and remodeling
- (2008) Brendan F. Boyce et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment
- (2008) Kousuke Iba et al. JOURNAL OF ORTHOPAEDIC SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started